Skip to main content

Cancer Therapy-Induced Inflammation and Its Consequences

  • Chapter
  • First Online:
Biotechnology Applied to Inflammatory Diseases

Abstract

The inflammatory process often modifies the natural history of cancers. There is broad evidence that chronic inflammatory responses, associated with, e.g., persistent viral or bacterial infections, promote carcinogenesis. Cancer treatment is also associated with an inflammatory process that may either induce an antitumor immune response or, conversely, favor tumor recurrence. Here, we will revise the major aspects of therapy-induced inflammation and its consequences for tumor recurrence or repopulation, emphasizing how the mode of tumor cell death elicits an antitumor response, the key elements associated with the clearance of dead cells within the tumor microenvironment and the unleashing of an innate tissue regenerative response, dependent on lipid mediators such as prostaglandin E2 and the platelet activation factor (PAF), that favor tumor regrowth. Therapy-induced inflammation may offer a window of opportunity for combination therapies that increase the effectiveness of conventional cancer treatment modalities. Nanobiotechnology offers versatile platforms for anti-inflammatory interventions. Here we also discuss RNA-based approaches in the nanoscale, which would allow targeted interventions of pro-tumoral inflammatory milieu assembled in the course of therapeutic regimens in order to avoid the emergence of treatment-resistant cancer cells that ultimately repopulate the tumor mass.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Afonin KA, Grabow WW, Walker FM, Bindewald E, Dobrovolskaia MA, Shapiro BA, Jaeger L (2011) Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat Protoc 6(12):2022–2034

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Afonin KA, Viard M, Koyfman AY, Martins AN, Kasprzak WK, Panigaj M, Desai R, Santhanam A, Grabow WW, Jaeger L, Heldman E, Reiser J, Chiu W, Freed EO, Shapiro BA (2014) Multifunctional RNA nanoparticles. Nano Lett 14(10):5662–5671

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Afonin KA, Dobrovolskaia MA, Church G, Bathe M (2020) Opportunities, barriers, and a strategy for overcoming translational challenges to therapeutic nucleic acid nanotechnology. ACS Nano 14(8):9221–9227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413(6857):732–738

    Article  CAS  PubMed  Google Scholar 

  • Alfaro C, Suárez N, Martínez-Forero I, Palazón A, Rouzaut A, Solano S, Feijoo E, Gúrpide A, Bolaños E, Erro L, Dubrot J, Hervás-Stubbs S, Gonzalez A, Perez-Gracia JL, Melero I (2011) Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation. PLoS One 6(3):e17922

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alfaro C, Teijeira A, Oñate C, Pérez G, Sanmamed MF, Andueza MP, Alignani D, Labiano S, Azpilikueta A, Rodriguez-Paulete A, Garasa S, Fusco JP, Aznar A, Inogés S, De Pizzol M, Allegretti M, Medina-Echeverz J, Berraondo P, Perez-Gracia JL, Melero I (2016) Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs). Clin Cancer Res 22(15):3924–3936

    Article  CAS  PubMed  Google Scholar 

  • Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL (2007) Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res 67(14):6854–6862

    Article  CAS  PubMed  Google Scholar 

  • Arnold T, Michlmayr A, Baumann S, Burghuber C, Pluschnig U, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R (2013) Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer. Eur J Clin Investig 43(3):286–291

    Article  CAS  Google Scholar 

  • Avila YI, Chandler M, Cedrone E, Newton HS, Richardson M, Xu J, Clogston JD, Liptrott NJ, Afonin KA, Dobrovolskaia MA (2021) Induction of cytokines by nucleic acid nanoparticles (NANPs) depends on the type of delivery carrier. Molecules 26(3):652

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bachi AL, Dos Santos LC, Nonogaki S, Jancar S, Jasiulionis MG (2012) Apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor. Mediat Inflamm 2012:610371

    Article  Google Scholar 

  • Barber GN (2015) STING: infection, inflammation and cancer. Nat Rev Immunol 15(12):760–770

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Barber LA, Spandau DF, Rathman SC, Murphy RC, Johnson CA, Kelley SW, Hurwitz SA, Travers JB (1998) Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem 273(30):18891–18897

    Article  CAS  PubMed  Google Scholar 

  • Basingab FS, Ahmadi M, Morgan DJ (2016) IFNγ-dependent interactions between ICAM-1 and LFA-1 counteract prostaglandin E2-mediated inhibition of antitumor CTL responses. Cancer Immunol Res 4(5):400–411

    Article  CAS  PubMed  Google Scholar 

  • Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81(1):1–5

    Article  CAS  PubMed  Google Scholar 

  • Bisogno LS, Keene JD (2018) RNA regulons in cancer and inflammation. Curr Opin Genet Dev 48:97–103

    Article  CAS  PubMed  Google Scholar 

  • Bonner JA, Trummell HQ, Willey CD, Plants BA, Raisch KP (2009) Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma. Radiother Oncol 92(3):339–344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bradbury CM, Markovina S, Wei SJ, Rene LM, Zoberi I, Horikoshi N, Gius D (2001) Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. Cancer Res 61(20):7689–7696

    CAS  PubMed  Google Scholar 

  • Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Métivier D, Pichard E, Aucouturier P, Pierron G, Garrido C, Zitvogel L, Kroemer G (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202(12):1691–1701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chammas R, de Sousa Andrade LN, Jancar S (2017) Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy. Nat Rev Cancer 17(4):253

    Article  CAS  PubMed  Google Scholar 

  • Chandler M, Afonin KA (2019) Smart-responsive nucleic acid nanoparticles (NANPs) with the potential to modulate immune behavior. Nanomaterials (Basel) 9(4):611

    Article  CAS  PubMed  Google Scholar 

  • Chandler M, Johnson MB, Panigaj M, Afonin KA (2019) Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs). Curr Opin Biotechnol 63:8–15

    Article  PubMed  PubMed Central  Google Scholar 

  • Chandler M, Johnson MB, Panigaj M, Afonin KA (2020) Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs). Curr Opin Biotechnol 63:8–15

    Article  CAS  PubMed  Google Scholar 

  • Chandrasekar D, Sistla R, Ahmad FJ, Khar RK, Diwan PV (2007) The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials 28(3):504–512

    Article  CAS  PubMed  Google Scholar 

  • Chauhan AS, Diwan PV, Jain NK, Tomalia DA (2009) Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules 10(5):1195–1202

    Article  CAS  PubMed  Google Scholar 

  • Cho MH, Yoo TG, Jeong SM, Shin DW (2020) Association of aspirin, metformin, and statin use with gastric cancer incidence and mortality: a Nationwide Cohort study. Cancer Prev Res (Phila) 14(1):95–104

    Article  PubMed  Google Scholar 

  • Chow MT, Luster AD (2014) Chemokines in cancer. Cancer Immunol Res 2(12):1125–1131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chung EY, Kim SJ, Ma XJ (2006) Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res 16(2):154–161

    Article  CAS  PubMed  Google Scholar 

  • Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100(2):228–237

    Article  PubMed  Google Scholar 

  • da Silva IA, Chammas R, Lepique AP, Jancar S (2017) Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy. Oncogenesis 6(1):e296

    Article  PubMed  Google Scholar 

  • De Marcken M, Dhaliwal K, Danielsen AC, Gautron AS, Dominguez-Villar M (2019) TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection. Sci Signal 12(605):eaaw1347

    Article  PubMed  Google Scholar 

  • de Oliveira SI, Fernandes PD, Amarante Mendes JG, Jancar S (2006) Phagocytosis of apoptotic and necrotic thymocytes is inhibited by PAF-receptor antagonists and affects LPS-induced COX-2 expression in murine macrophages. Prostaglandins Other Lipid Mediat 80(1–2):62–73

    Article  PubMed  Google Scholar 

  • de Oliveira SI, Andrade LN, Onuchic AC, Nonogaki S, Fernandes PD, Pinheiro MC, Rohde CB, Chammas R, Jancar S (2010) Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer 10:200

    Article  PubMed  PubMed Central  Google Scholar 

  • Desborough JP (2000) The stress response to trauma and surgery. Br J Anaesth 85(1):109–117

    Article  CAS  PubMed  Google Scholar 

  • Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, Gilardi MC, Bravatà V (2015) Portrait of inflammatory response to ionizing radiation treatment. J Inflamm (Lond) 12:14

    Article  PubMed  Google Scholar 

  • Dinarello CA (2006) The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 25(3):307–313

    Article  CAS  PubMed  Google Scholar 

  • Dobrovolskaia MA (2019) Nucleic acid nanoparticles at a crossroads of vaccines and immunotherapies. Molecules 24(24):4620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dobrovolskaia MA, Afonin KA (2020) Use of human peripheral blood mononuclear cells to define immunological properties of nucleic acid nanoparticles. Nat Protoc 15(11):3678–3698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dobrovolskaia MA, McNeil SE (2015) Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics. Expert Opin Drug Deliv 12(7):1163–1175

    Article  CAS  PubMed  Google Scholar 

  • Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM (2012) CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Neoplasia 14(8):709–718

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Feijoó E, Alfaro C, Mazzolini G, Serra P, Peñuelas I, Arina A, Huarte E, Tirapu I, Palencia B, Murillo O, Ruiz J, Sangro B, Richter JA, Prieto J, Melero I (2005) Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer 116(2):275–281

    Article  PubMed  Google Scholar 

  • Ferracini M, Rios FJ, Pecenin M, Jancar S (2013) Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of CD36 and platelet-activating factor receptor. Mediat Inflamm 2013:950273

    Article  Google Scholar 

  • Finetti F, Travelli C, Ercoli J, Colombo G, Buoso E, Trabalzini L (2020) Prostaglandin E2 and cancer: insight into tumor progression and immunity. Biology (Basel) 9(12):434

    CAS  PubMed  Google Scholar 

  • Fishbein A, Wang W, Yang H, Yang J, Hallisey VM, Deng J, Verheul SML, Hwang SH, Gartung A, Wang Y, Bielenberg DR, Huang S, Kieran MW, Hammock BD, Panigrahy D (2020) Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression. Proc Natl Acad Sci U S A 117(35):21576–21587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fishbein A, Hammock BD, Serhan CN, Panigrahy D (2021) Carcinogenesis: failure of resolution of inflammation? Pharmacol Ther 218:107670

    Article  CAS  PubMed  Google Scholar 

  • Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, Gaipl US, Gameiro SR, Garg AD, Golden E, Han J, Harrington KJ, Hemminki A, Hodge JW, Hossain DMS, Illidge T, Karin M, Kaufman HL, Kepp O, Kroemer G, Lasarte JJ, Loi S, Lotze MT, Manic G, Merghoub T, Melcher AA, Mossman KL, Prosper F, Rekdal Ø, Rescigno M, Riganti C, Sistigu A, Smyth MJ, Spisek R, Stagg J, Strauss BE, Tang D, Tatsuno K, van Gool SW, Vandenabeele P, Yamazaki T, Zamarin D, Zitvogel L, Cesano A, Marincola FM (2020) Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer 8(1):e000337

    Article  PubMed  PubMed Central  Google Scholar 

  • Gandhi S, Chandna S (2017) Radiation-induced inflammatory cascade and its reverberating crosstalks as potential cause of post-radiotherapy second malignancies. Cancer Metastasis Rev 36(2):375–393

    Article  CAS  PubMed  Google Scholar 

  • Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJ, Annaert W, Golab J, de Witte P, Vandenabeele P, Agostinis P (2012) A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 31(5):1062–1079

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gartung A, Yang J, Sukhatme VP, Bielenberg DR, Fernandes D, Chang J, Schmidt BA, Hwang SH, Zurakowski D, Huang S, Kieran MW, Hammock BD, Panigrahy D (2019) Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor. Proc Natl Acad Sci U S A 116(5):1698–1703

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gorchs L, Fernández Moro C, Bankhead P, Kern KP, Sadeak I, Meng Q, Rangelova E, Kaipe H (2019) Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4. Front Immunol 10:847

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Green DR, Oguin TH, Martinez J (2016) The clearance of dying cells: table for two. Cell Death Differ 23(6):915–926

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gregory CD, Devitt A (2004) The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113(1):1–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guo S, Li H, Ma M, Fu J, Dong Y, Guo P (2017) Size, shape, and sequence-dependent immunogenicity of RNA nanoparticles. Mol Ther Nucleic Acids 9:399–408

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Halman JR, Satterwhite E, Roark B, Chandler M, Viard M, Ivanina A, Bindewald E, Kasprzak WK, Panigaj M, Bui MN, Lu JS, Miller J, Khisamutdinov EF, Shapiro BA, Dobrovolskaia MA, Afonin KA (2017) Functionally-interdependent shape-switching nanoparticles with controllable properties. Nucleic Acids Res 45(4):2210–2220

    CAS  PubMed  PubMed Central  Google Scholar 

  • Halman JR, Kim K-T, Gwak S-J, Pace R, Johnson MB, Chandler MR, Rackley L, Viard M, Marriott I, Lee JS, Afonin KA (2020) A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution. Nanomedicine 23:102094

    Article  CAS  PubMed  Google Scholar 

  • Hambek M, Baghi M, Wagenblast J, Schmitt J, Baumann H, Knecht R (2007) Inverse correlation between serum PGE2 and T classification in head and neck cancer. Head Neck 29(3):244–248

    Article  PubMed  Google Scholar 

  • Heil F (2004) Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303(5663):1526–1529

    Article  CAS  PubMed  Google Scholar 

  • Hernandez C, Huebener P, Schwabe RF (2016) Damage-associated molecular patterns in cancer: a double-edged sword. Oncogene 35(46):5931–5941

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hong JH, Chiang CS, Campbell IL, Sun JR, Withers HR, McBride WH (1995) Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33(3):619–626

    Article  CAS  PubMed  Google Scholar 

  • Hong E, Halman JR, Shah AB, Khisamutdinov EF, Dobrovolskaia MA, Afonin KA (2018) Structure and composition define immunorecognition of nucleic acid nanoparticles. Nano Lett 18(7):4309–4321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hong E, Halman JR, Shah A, Cedrone E, Truong N, Afonin KA, Dobrovolskaia MA (2019) Toll-like receptor-mediated recognition of nucleic acid nanoparticles (NANPs) in human primary blood cells. Molecules 24(6):1094

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann K-K, Schlee M, Endres S, Hartmann G (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314(5801):994–997

    Article  PubMed  Google Scholar 

  • Howard KA, Paludan SR, Behlke MA, Besenbacher F, Deleuran B, Kjems J (2009) Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther 17(1):162–168

    Article  CAS  PubMed  Google Scholar 

  • Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O'Sullivan B, He Z, Peng Y, Tan AC, Zhou L, Shen J, Han G, Wang XJ, Thorburn J, Thorburn A, Jimeno A, Raben D, Bedford JS, Li CY (2011) Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 17(7):860–866

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hui Z, Tretiakova M, Zhang Z, Li Y, Wang X, Zhu JX, Gao Y, Mai W, Furge K, Qian CN, Amato R, Butler EB, Teh BT, Teh BS (2009) Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Int J Radiat Oncol Biol Phys 73(1):288–295

    Article  CAS  PubMed  Google Scholar 

  • Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109(1):41–50

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ilinskaya AN, Dobrovolskaia MA (2014) Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol 171(17):3988–4000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ishii S, Shimizu T (2000) Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39(1):41–82

    Article  CAS  PubMed  Google Scholar 

  • Ishizuka EK, Filgueiras LR, Rios FJ, Serezani CH, Jancar S (2016) PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages. Sci Rep 6:32092

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iyer R, Lehnert BE, Svensson R (2000) Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Res 60(5):1290–1298

    CAS  PubMed  Google Scholar 

  • Johnson MB, Halman JR, Satterwhite E, Zakharov AV, Bui MN, Benkato K, Goldsworthy V, Kim T, Hong E, Dobrovolskaia MA, Khisamutdinov EF, Marriott I, Afonin KA (2017) Programmable nucleic acid based polygons with controlled neuroimmunomodulatory properties for predictive QSAR modeling. Small 13(42):1255

    Article  Google Scholar 

  • Johnson MB, Halman JR, Miller DK, Cooper JS, Khisamutdinov F, Emil IM, Afonin KA (2020) The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification. Nucleic Acids Res 48(20):11785–11798

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jung M, Zhang Y, Lee S, Dritschilo A (1995) Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science 268(5217):1619–1621

    Article  CAS  PubMed  Google Scholar 

  • Kawamori T, Uchiya N, Nakatsugi S, Watanabe K, Ohuchida S, Yamamoto H, Maruyama T, Kondo K, Sugimura T, Wakabayashi K (2001) Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development. Carcinogenesis 22(12):2001–2004

    Article  CAS  PubMed  Google Scholar 

  • Ke W, Hong E, Saito RF, Rangel MC, Wang J, Viard M, Richardson M, Khisamutdinov EF, Panigaj M, Dokholyan NV, Chammas R, Dobrovolskaia MA, Afonin KA (2019) RNA–DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-kappaB in human cells. Nucleic Acids Res 47(3):1350–1361

    Article  CAS  PubMed  Google Scholar 

  • Kim KW, Mutter RW, Cao C, Albert JM, Shinohara ET, Sekhar KR, Lu B (2006) Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation. Mol Cancer Ther 5(11):2659–2665

    Article  CAS  PubMed  Google Scholar 

  • Koga MM, Bizzarro B, Sá-Nunes A, Rios FJ, Jancar S (2013) Activation of PAF-receptor induces regulatory dendritic cells through PGE2 and IL-10. Prostaglandins Leukot Essent Fatty Acids 89(5):319–326

    Article  CAS  PubMed  Google Scholar 

  • Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12(12):860–875

    Article  CAS  PubMed  Google Scholar 

  • Kuraishy A, Karin M, Grivennikov SI (2011) Tumor promotion via injury- and death-induced inflammation. Immunity 35(4):467–477

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL, Chan KS (2015) Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature 517(7533):209–213

    Article  CAS  PubMed  Google Scholar 

  • Latz E, Visintin A, Espevik T, Golenbock DT (2004) Mechanisms of TLR9 activation. J Endotoxin Res 10(6):406–412

    Article  CAS  PubMed  Google Scholar 

  • Lemke G, Rothlin CV (2008) Immunobiology of the TAM receptors. Nat Rev Immunol 8(5):327–336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Leonard JN, Ghirlando R, Askins J, Bell JK, Margulies DH, Davies DR, Segal DM (2008) The TLR3 signaling complex forms by cooperative receptor dimerization. Proc Natl Acad Sci 105(1):258–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott SM, Zimmerman GA (1988) Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 82(6):2045–2055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Y, Fang M, Zhang J, Wang J, Song Y, Shi J, Li W, Wu G, Ren J, Wang Z, Zou W, Wang L (2016) Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. Onco Targets Ther 5(2):e1074374

    Google Scholar 

  • Lin YS, Yeh CC, Huang SF, Chou YS, Kuo LT, Sung FC, Muo CH, Su CT, Su FH (2018) Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: a population-based analysis. PLoS One 13(8):e0199014

    Article  PubMed  PubMed Central  Google Scholar 

  • Lin Y-X, Wang Y, Blake S, Yu M, Mei L, Wang H, Shi J (2020) RNA nanotechnology-mediated cancer immunotherapy. Theranostics 10(1):281–299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loo Y-M, Gale M (2011) Immune signaling by RIG-I-like receptors. Immunity 34(5):680–692

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lordan R, Tsoupras A, Zabetakis I, Demopoulos CA (2019) Forty years since the structural elucidation of platelet-activating factor (PAF): historical, current, and future research perspectives. Molecules 24(23):4414

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci 101(15):5598–5603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luo Y, Chihara Y, Fujimoto K, Sasahira T, Kuwada M, Fujiwara R, Fujii K, Ohmori H, Kuniyasu H (2013) High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. Eur J Cancer 49(3):741–751

    Article  CAS  PubMed  Google Scholar 

  • Ma Y, Brusselaers N (2018) Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk. Prostate Cancer Prostatic Dis 21(1):147–152

    Article  CAS  PubMed  Google Scholar 

  • Magné N, Toillon RA, Bottero V, Didelot C, Houtte PV, Gérard JP, Peyron JF (2006) NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett 231(2):158–168

    Article  PubMed  Google Scholar 

  • Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146(1):3–15

    CAS  PubMed  PubMed Central  Google Scholar 

  • Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991–1045

    Article  CAS  PubMed  Google Scholar 

  • McLemore TL, Hubbard WC, Litterst CL, Liu MC, Miller S, McMahon NA, Eggleston JC, Boyd MR (1988) Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res 48(11):3140–3147

    CAS  PubMed  Google Scholar 

  • Miao J, Lu X, Hu Y, Piao C, Wu X, Liu X, Huang C, Wang Y, Li D, Liu J (2017) Prostaglandin E. Oncotarget 8(52):89802–89810

    Article  PubMed  PubMed Central  Google Scholar 

  • Mollica Poeta V, Massara M, Capucetti A, Bonecchi R (2019) Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol 10:379

    Article  PubMed  PubMed Central  Google Scholar 

  • Motwani M, Pesiridis S, Fitzgerald KA (2019) DNA sensing by the cGAS–STING pathway in health and disease. Nat Rev Genet 20(11):657–674

    Article  CAS  PubMed  Google Scholar 

  • Nakhaei P, Hiscott J, Lin R (2010) STING-ing the antiviral pathway. J Mol Cell Biol 2(3):110–112

    Article  CAS  PubMed  Google Scholar 

  • Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13(1):54–61

    Article  CAS  PubMed  Google Scholar 

  • Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P, Chen JF, Jackson EK, Apasov S, Abrams S, Sitkovsky M (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 103(35):13132–13137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Onuchic AC, Machado CM, Saito RF, Rios FJ, Jancar S, Chammas R (2012) Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma. Mediat Inflamm 2012:175408

    Article  Google Scholar 

  • Oshima H, Hioki K, Popivanova BK, Oguma K, Van Rooijen N, Ishikawa TO, Oshima M (2011) Prostaglandin E2 signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology 140(2):596–607

    Article  CAS  PubMed  Google Scholar 

  • Panigaj M, Johnson MB, Ke W, McMillan J, Goncharova EA, Chandler M, Afonin KA (2019) Aptamers as modular components of therapeutic nucleic acid nanotechnology. ACS Nano 13(11):12301–12321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paquette B, Therriault H, Wagner JR (2013) Role of interleukin-1β in radiation-enhancement of MDA-MB-231 breast cancer cell invasion. Radiat Res 180(3):292–298

    Article  CAS  PubMed  Google Scholar 

  • Pasi F, Facoetti A, Nano R (2010) IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation. Anticancer Res 30(7):2769–2772

    CAS  PubMed  Google Scholar 

  • Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK (2011) RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11(1):59–67

    Article  CAS  PubMed  Google Scholar 

  • Porta C, Consonni FM, Morlacchi S, Sangaletti S, Bleve A, Totaro MG, Larghi P, Rimoldi M, Tripodo C, Strauss L, Banfi S, Storto M, Pressiani T, Rimassa L, Tartari S, Ippolito A, Doni A, Soldà G, Duga S, Piccolo V, Ostuni R, Natoli G, Bronte V, Balzac F, Turco E, Hirsch E, Colombo MP, Sica A (2020) Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSCs. Cancer Res 80(13):2874–2888

    Article  CAS  PubMed  Google Scholar 

  • Prima V, Kaliberova LN, Kaliberov S, Curiel DT, Kusmartsev S (2017) COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proc Natl Acad Sci U S A 114(5):1117–1122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rackley L, Stewart JM, Salotti J, Krokhotin A, Shah A, Halman JR, Juneja R, Smollett J, Lee L, Roark K, Viard M, Tarannum M, Vivero-Escoto J, Johnson PF, Dobrovolskaia MA, Dokholyan NV, Franco E, Afonin KA (2018) RNA fibers as optimized nanoscaffolds for siRNA coordination and reduced immunological recognition. Adv Funct Mater 28(48):5959

    Article  Google Scholar 

  • Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256(2):137–165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ranjith-Kumar CT, Miller W, Xiong J, Russell WK, Lamb R, Santos J, Duffy KE, Cleveland L, Park M, Bhardwaj K, Wu Z, Russell DH, Sarisky RT, Mbow ML, Kao CC (2007) Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J Biol Chem 282(10):7668–7678

    Article  CAS  PubMed  Google Scholar 

  • Reers S, Pfannerstill AC, Rades D, Maushagen R, Andratschke M, Pries R, Wollenberg B (2013) Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. Anticancer Res 33(6):2481–2489

    CAS  PubMed  Google Scholar 

  • Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122(5):518–523

    CAS  PubMed  Google Scholar 

  • Rios FJ, Koga MM, Pecenin M, Ferracini M, Gidlund M, Jancar S (2013) Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR. Mediat Inflamm 2013:198193

    Article  Google Scholar 

  • Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33(1):99–109

    Article  CAS  PubMed  Google Scholar 

  • Sahu RP, Turner MJ, DaSilva SC, Rashid BM, Ocana JA, Perkins SM, Konger RL, Touloukian CE, Kaplan MH, Travers JB (2012) The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. Carcinogenesis 33(7):1360–1367

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK, Perkins SM, Speicher PJ, Tyler DS, Konger RL, Travers JB (2014) Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. Cancer Res 74(23):7069–7078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sahu RP, Harrison KA, Weyerbacher J, Murphy RC, Konger RL, Garrett JE, Chin-Sinex HJ, Johnston ME, Dynlacht JR, Mendonca M, McMullen K, Li G, Spandau DF, Travers JB (2016) Radiation therapy generates platelet-activating factor agonists. Oncotarget 7(15):20788–20800

    Article  PubMed  PubMed Central  Google Scholar 

  • Schaue D, Kachikwu EL, McBride WH (2012) Cytokines in radiobiological responses: a review. Radiat Res 178(6):505–523

    Article  PubMed  PubMed Central  Google Scholar 

  • Sepah SC, Bower JE (2009) Positive affect and inflammation during radiation treatment for breast and prostate cancer. Brain Behav Immun 23(8):1068–1072

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Serhan CN, Levy BD (2018) Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 128(7):2657–2669

    Article  PubMed  PubMed Central  Google Scholar 

  • Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Huang M, Batra RK, Dubinett SM (2005) Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res 65(12):5211–5220

    Article  CAS  PubMed  Google Scholar 

  • Sharma B, Nawandar DM, Nannuru KC, Varney ML, Singh RK (2013) Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis. Mol Cancer Ther 12(5):799–808

    Article  CAS  PubMed  Google Scholar 

  • Shimabukuro-Vornhagen A, Liebig TM, Koslowsky T, Theurich S, von Bergwelt-Baildon MS (2013) The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect. Cell Immunol 281(1):62–67

    Article  CAS  PubMed  Google Scholar 

  • Skvortsova I, Skvortsov S, Stasyk T, Raju U, Popper BA, Schiestl B, von Guggenberg E, Neher A, Bonn GK, Huber LA, Lukas P (2008) Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics 8(21):4521–4533

    Article  CAS  PubMed  Google Scholar 

  • Sprowl JA, Reed K, Armstrong SR, Lanner C, Guo B, Kalatskaya I, Stein L, Hembruff SL, Tam A, Parissenti AM (2012) Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells. Breast Cancer Res 14(1):R2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A (2002) Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol 168(4):1627–1635

    Article  CAS  PubMed  Google Scholar 

  • Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282(16):11613–11617

    Article  CAS  PubMed  Google Scholar 

  • Sulciner ML, Serhan CN, Gilligan MM, Mudge DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli J, Greene ER, Gus-Brautbar Y, Piwowarski J, Mammoto T, Zurakowski D, Perretti M, Sukhatme VP, Kaipainen A, Kieran MW, Huang S, Panigrahy D (2018) Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med 215(1):115–140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805–820

    Article  CAS  PubMed  Google Scholar 

  • Tamatani T, Azuma M, Ashida Y, Motegi K, Takashima R, Harada K, Kawaguchi S, Sato M (2004) Enhanced radiosensitization and chemosensitization in NF-kappaB-suppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8. Int J Cancer 108(6):912–921

    Article  CAS  PubMed  Google Scholar 

  • Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Yang B, Hayasaka H, Miyasaka M (2005) Chemokines in tumor progression and metastasis. Cancer Sci 96(6):317–322

    Article  CAS  PubMed  Google Scholar 

  • Toste PA, Nguyen AH, Kadera BE, Duong M, Wu N, Gawlas I, Tran LM, Bikhchandani M, Li L, Patel SG, Dawson DW, Donahue TR (2016) Chemotherapy-induced inflammatory gene signature and protumorigenic phenotype in pancreatic CAFs via stress-associated MAPK. Mol Cancer Res 14(5):437–447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA (2009) The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets 9(4):390–399

    Article  CAS  PubMed  Google Scholar 

  • Ullrich SE (2005) Mechanisms underlying UV-induced immune suppression. Mutat Res 571(1–2):185–205

    Article  CAS  PubMed  Google Scholar 

  • Veettil SK, Lim KG, Ching SM, Saokaew S, Phisalprapa P, Chaiyakunapruk N (2017) Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials. BMC Cancer 17(1):763

    Article  PubMed  PubMed Central  Google Scholar 

  • Vyas D, Laput G, Vyas AK (2014) Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther 7:1015–1023

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang D, Dubois RN (2004) Cyclooxygenase-2: a potential target in breast cancer. Semin Oncol 31(1 Suppl 3):64–73

    Article  CAS  PubMed  Google Scholar 

  • Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10(3):181–193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang D, DuBois RN (2018) Role of prostanoids in gastrointestinal cancer. J Clin Invest 128(7):2732–2742

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, Mobley GM, Liao Z (2010) Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun 24(6):968–974

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Y, Qu Y, Niu XL, Sun WJ, Zhang XL, Li LZ (2011) Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cytokine 56(2):365–375

    Article  CAS  PubMed  Google Scholar 

  • Wang R, Zhou T, Liu W, Zuo L (2018) Molecular mechanism of bystander effects and related abscopal/cohort effects in cancer therapy. Oncotarget 9(26):18637–18647

    Article  PubMed  PubMed Central  Google Scholar 

  • Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14(21):6735–6741

    Article  CAS  PubMed  Google Scholar 

  • Wilson C, Wilson T, Johnston PG, Longley DB, Waugh DJ (2008) Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells. Mol Cancer Ther 7(9):2649–2661

    Article  CAS  PubMed  Google Scholar 

  • Wu CT, Chen MF, Chen WC, Hsieh CC (2013) The role of IL-6 in the radiation response of prostate cancer. Radiat Oncol 8:159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang C, Gao S, Kjems J (2014) Folic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivo. J Mater Chem B 2(48):8608–8615

    Article  CAS  PubMed  Google Scholar 

  • Yang F, Wei Y, Cai Z, Yu L, Jiang L, Zhang C, Yan H, Wang Q, Cao X, Liang T, Wang J (2015) Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling. Cell Mol Immunol 12(1):66–76

    Article  CAS  PubMed  Google Scholar 

  • Yin J, Kim SS, Choi E, Oh YT, Lin W, Kim TH, Sa JK, Hong JH, Park SH, Kwon HJ, Jin X, You Y, Kim JH, Kim H, Son J, Lee J, Nam DH, Choi KS, Shi B, Gwak HS, Yoo H, Iavarone A, Park JB (2020) ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages. Nat Commun 11(1):2978

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yourston L, Rolband L, West C, Lushnikov A, Afonin KA, Krasnoslobodtsev AVJN (2020) Tuning properties of silver nanoclusters with RNA nanoring assemblies. Nanoscale 12(30):16189–16200

    Article  CAS  PubMed  Google Scholar 

  • Zelenay S, van der Veen AG, Böttcher JP, Snelgrove KJ, Rogers N, Acton SE, Chakravarty P, Girotti MR, Marais R, Quezada SA, Sahai E, Reis e Sousa C (2015) Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162(6):1257–1270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang JS, Nakatsugawa S, Niwa O, Ju GZ, Liu SZ (1994) Ionizing radiation-induced IL-1 alpha, IL-6 and GM-CSF production by human lung cancer cells. Chin Med J 107(9):653–657

    CAS  PubMed  Google Scholar 

  • Zhang G, Panigrahy D, Hwang SH, Yang J, Mahakian LM, Wettersten HI, Liu JY, Wang Y, Ingham ES, Tam S, Kieran MW, Weiss RH, Ferrara KW, Hammock BD (2014) Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Proc Natl Acad Sci U S A 111(30):11127–11132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Z, Ohto U, Shibata T, Taoka M, Yamauchi Y, Sato R, Shukla NM, David SA, Isobe T, Miyake K, Shimizu T (2018) Structural analyses of Toll-like receptor 7 reveal detailed RNA sequence specificity and recognition mechanism of agonistic ligands. Cell Rep 25(12):3371–3381

    Article  CAS  PubMed  Google Scholar 

  • Zhou J, Chen X, Gilvary DL, Tejera MM, Eksioglu EA, Wei S, Djeu JY (2015) HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells. Sci Rep 5:15085

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers R01GM120487 and R35GM139587 (to K.A.A), Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/50029-6, to RC and KAA) and Conselho Nacional de Pesquisa e Desenvolvimento (426714/2016-0 and 305700/2017-0, to RC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roger Chammas .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

de Freitas Saito, R., Rangel, M.C., Chandler, M., Beasock, D., Afonin, K.A., Chammas, R. (2023). Cancer Therapy-Induced Inflammation and Its Consequences. In: Ribeiro de Araujo, D., Carneiro-Ramos, M. (eds) Biotechnology Applied to Inflammatory Diseases. Interdisciplinary Biotechnological Advances. Springer, Singapore. https://doi.org/10.1007/978-981-19-8342-9_4

Download citation

Publish with us

Policies and ethics